Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -37.13%36.93K | -29.43%200.73K | -43.82%38.8K | -43.96%41.64K | -20.00%61.56K | -8.43%58.73K | 54.72%284.45K | -7.28%69.06K | 119.87%74.3K | 40.26%76.96K |
| Selling and administrative expenses | -40.08%33.61K | -29.43%200.73K | -43.82%38.8K | -43.96%41.64K | -20.00%61.56K | -12.55%56.09K | 54.72%284.45K | -7.28%69.06K | 119.87%74.3K | 40.26%76.96K |
| -General and administrative expense | -40.08%33.61K | -29.43%200.73K | -43.82%38.8K | -43.96%41.64K | -20.00%61.56K | -12.55%56.09K | 54.72%284.45K | -7.28%69.06K | 119.87%74.3K | 40.26%76.96K |
| Other operating expenses | 25.45%3.32K | ---- | ---- | ---- | ---- | --2.64K | ---- | ---- | ---- | ---- |
| Operating profit | 37.13%-36.93K | 29.43%-200.73K | 43.82%-38.8K | 43.96%-41.64K | 20.00%-61.56K | 8.43%-58.73K | -54.72%-284.45K | 7.28%-69.06K | -119.87%-74.3K | -40.26%-76.96K |
| Net non-operating interest income (expenses) | 0 | -88.56%1.62K | -96.04%85 | -97.99%68 | -89.33%436 | -77.26%1.03K | -20.90%14.13K | -65.84%2.14K | 12.65%3.38K | -9.40%4.09K |
| Non-operating interest income | --0 | -88.56%1.62K | -96.04%85 | -97.99%68 | -89.33%436 | -77.26%1.03K | -20.90%14.13K | -65.84%2.14K | 12.65%3.38K | -9.40%4.09K |
| Other net income (expenses) | ||||||||||
| Income before tax | 36.01%-36.93K | 26.34%-199.11K | 42.15%-38.71K | 41.39%-41.57K | 16.11%-61.13K | 3.20%-57.7K | -62.86%-270.32K | 1.89%-66.92K | -130.31%-70.92K | -44.71%-72.87K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 36.01%-36.93K | 26.34%-199.11K | 42.15%-38.71K | 41.39%-41.57K | 16.11%-61.13K | 3.20%-57.7K | -62.86%-270.32K | 1.89%-66.92K | -130.31%-70.92K | -44.71%-72.87K |
| Net income continuous operations | 36.01%-36.93K | 26.34%-199.11K | 42.15%-38.71K | 41.39%-41.57K | 16.11%-61.13K | 3.20%-57.7K | -62.86%-270.32K | 1.89%-66.92K | -130.31%-70.92K | -44.71%-72.87K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 36.01%-36.93K | 26.34%-199.11K | 42.15%-38.71K | 41.39%-41.57K | 16.11%-61.13K | 3.20%-57.7K | -62.86%-270.32K | 1.89%-66.92K | -130.31%-70.92K | -44.71%-72.87K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 36.01%-36.93K | 26.34%-199.11K | 42.15%-38.71K | 41.39%-41.57K | 16.11%-61.13K | 3.20%-57.7K | -62.86%-270.32K | 1.89%-66.92K | -130.31%-70.92K | -44.71%-72.87K |
| Diluted earnings per share | 0.00%-0.002 | 0.00%-0.01 | -0.003 | 33.33%-0.002 | 0.00%-0.003 | 0.00%-0.002 | 0.00%-0.01 | 0 | -200.00%-0.003 | -50.00%-0.003 |
| Basic earnings per share | 0.00%-0.002 | 0.00%-0.01 | -0.003 | 33.33%-0.002 | 0.00%-0.003 | 0.00%-0.002 | 0.00%-0.01 | 0 | -200.00%-0.003 | -50.00%-0.003 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.